STRATA Skin Sciences announced the expansion of a direct distribution agreement with Kosmo Meditech, which is now assigned to Kosmo’s corporate parent, Cutech, Inc., effective as of January 1, 2024, for a combination of direct capital sales and direct recurring revenue sales in Korea. The key highlights of this amendment, which reinforce STRATA’s commitment to innovation and customer satisfaction, include: Extended term through December 31, 2026, ensuring a prolonged and stable partnership; Established defined annual and quarterly performance-based purchase requirements, including STRATA becoming sole provider of gas and consumables, securing a consistent demand for STRATA’s products, providing a reliable forecast for production and inventory management, and ensuring stronger top-line revenue
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SSKN:
- Strata Skin Sciences promotes Gov to Chief Operating Officer
- STRATA Skin Science Announces Strengthening of Leadership Team
- Strata Skin Sciences price target lowered to $3.20 from $3.80 at Ladenburg
- STRATA Skin Sciences Reports Third Quarter 2023 Revenue
- STRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023